The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial (Q36810441)

16 August 2017

The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial (English)

1 reference

16 August 2017

7

Robert Elashoff

1 reference

16 August 2017

8

Isidro B Salusky

1 reference

Katherine Wesseling-Perry

16 August 2017

2

object named as

Katherine Wesseling-Perry

1 reference

16 August 2017

5

Barbara Gales

1 reference

16 August 2017

Justine Bacchetta

1

1 reference

16 August 2017

Beatriz Kuizon

3

1 reference

16 August 2017

Renata C Pereira

4

1 reference

16 August 2017

He-jing Wang

6

1 reference

16 August 2017

4 April 2013

1 reference

Clinical Journal of the American Society of Nephrology

16 August 2017

1 reference

16 August 2017

8

1 reference

16 August 2017

5

1 reference

16 August 2017

824-832

1 reference

Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Technical approach to iliac crest biopsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Growth hormone for children with chronic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Adults with partial growth hormone deficiency have an adverse body composition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Bone disease in children and adolescents undergoing successful renal transplantation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641609

Treatment of growth failure with growth hormone in children with chronic kidney disease: an open-label long-term study

5 September 2018

1 reference

12 December 2020

Long-term recombinant human growth hormone use in Australian children with renal disease

1 reference

12 December 2020

Nutritional status of children undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients

1 reference

12 December 2020

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids

1 reference

12 December 2020

Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples

1 reference

12 December 2020

Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment

1 reference

12 December 2020

Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.00330112

1 reference

release_o7hx4ia3qffxxlx7xdczc35iou

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o7hx4ia3qffxxlx7xdczc35iou

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

1 reference